Bilski Test Stifles Innovation Across Industries: Briefs

By Erin Coe

Law360, New York (August 07, 2009, 5:06 PM ET) -- The Bilski test may have been crafted to limit patent eligibility for business methods, but the standard set by a federal appeals court in October 2008 is likely to exclude unforeseen innovations in the financial services, biotechnology, technology and other sectors, according to the latest set of amicus briefs filed with the U.S. Supreme Court.

The Biotechnology Industry Organization, a group of financial and computer firms, and the San Diego Intellectual Property Law Association filed separate briefs Thursday, arguing that the U.S. Court of Appeals for...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles